CBT
CBT
NYSE · Chemicals

Cabot Corp

$72.74
+2.03 (+2.87%)
As of Mar 25, 9:57 PM ET ·
Financial Highlights (FY 2026)
Revenue
3.56B
Net Income
317.41M
Gross Margin
25.3%
Profit Margin
8.9%
Rev Growth
-4.9%
D/E Ratio
0.73
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 25.3% 25.3% 49.7% 49.7%
Operating Margin 16.7% 15.1% 9.8% 10.6%
Profit Margin 8.9% 8.5% 7.8% 8.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.56B 3.75B 185.80M 154.67M
Gross Profit 901.53M 948.28M 92.35M 76.88M
Operating Income 595.68M 563.91M 18.27M 16.44M
Net Income 317.41M 300.48M 14.53M 13.23M
Gross Margin 25.3% 25.3% 49.7% 49.7%
Operating Margin 16.7% 15.1% 9.8% 10.6%
Profit Margin 8.9% 8.5% 7.8% 8.6%
Rev Growth -4.9% -4.9% +7.5% +12.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 822.77M 822.77M 777.42M 779.25M
Total Equity 1.13B 1.13B 2.58B 2.20B
D/E Ratio 0.73 0.73 0.30 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 736.47M 735.92M 24.94M 19.49M
Free Cash Flow 7.01M 6.93M